Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Ram Vaidhyanath

Neuroradiology

View

Dr. Judith Gadde

Neuroradiology · Lurie Children's Hospital

View

Dr. Wende Gibbs

Neuroradiology · Barrow Neurological Institute

View

Dr. Daniel Gewolb

Neuroradiology · University of Miami

View

Dr. Sumir Patel

Neuroradiology · Emory University

View

Dr. Julie Bulman

Interventional Radiology · BIDMC

View

Dr. Monica Sheth

Breast Imaging · NYU Langone

View

Dr. Victoria Chernyak

Abdominal Imaging · CUIMC

View

Dr. Laura Hayes

Peds Radiology · Children's Healthcare of Atlanta

View

Dr. Amy Patel

Breast Imaging · UKHS

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    ACR TI-RADS Risk Score Escalation Observed in Benign Thyroid Nodules following Radiofrequency Ablation.

    Apr 2, 2026DOI: 10.3174/ajnr.a9028Journal ArticleAJNR

    Written by: Tess J BattiolaRichard H WigginsDev Abraham

    Find these authors on Roon

    RW
    Dr. Richard Wiggins
    Neuroradiology · UUHC

    Summary

    BACKGROUND AND PURPOSE: Radiofrequency ablation (RFA) has emerged as an effective nonsurgical treatment for symptomatic benign thyroid nodules and toxic adenomas. While post-RFA ultrasonographic changes are expected, they may inadvertently evoke alarm and prompt unnecessary interventions when risk stratification models such as the American College of Radiology Thyroid Imaging Reporting & Data System (ACR TI-RADS) are applied. This study aims to quantify ultrasound imaging changes of thyroid nodules using TI-RADS scoring before and after RFA and highlights that these changes should not be used as a basis for clinical action.MATERIALS AND METHODS: This retrospective study analyzed patients who underwent RFA for symptomatic thyroid nodules at a quaternary care academic medical center between May 2021 and May 2024. All nodules were assessed using the ACR TI-RADS calculator and underwent fine-needle aspiration (FNA) biopsy before treatment. Following RFA, ultrasonography was conducted at 3-month intervals, and TI-RADS scores were reassessed. The primary end point was the change in TI-RADS classification following RFA.RESULTS: A total of 28 nodules from 25 patients were monitored after RFA for a median follow-up duration of 419 days. Most (92.9%) were benign (Bethesda II) on FNA. The mean volume reduction ratio (VRR) was 66.7% (range 33.0% to 91.6%), with therapeutic success (VRR >50%) achieved in 86% of patients. Post-RFA risk stratification increased following RFA, with the mean TI-RADS score increasing from 3.04 to 4.25 (P < .001), predominantly driven by increased hypoechogenicity and new echogenic foci/calcifications.CONCLUSIONS: Thyroid nodules frequently undergo post-RFA structural changes that result in misleading upstaging on the ACR TI-RADS stratification system. These changes are expected and require cautious interpretation to avoid overdiagnosis, patient anxiety, and mismanagement.
    RWDr. Richard Wiggins

    Dr. Richard Wiggins

    Radiology · Neuroradiology
    University of Utah Health Care
    richardw